YU11991A - RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE - Google Patents

RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE

Info

Publication number
YU11991A
YU11991A YU11991A YU11991A YU11991A YU 11991 A YU11991 A YU 11991A YU 11991 A YU11991 A YU 11991A YU 11991 A YU11991 A YU 11991A YU 11991 A YU11991 A YU 11991A
Authority
YU
Yugoslavia
Prior art keywords
procedure
expression
blood
well
virus
Prior art date
Application number
YU11991A
Other languages
Serbo-Croatian (sh)
Inventor
F.G. Falkner
Gillivray T.A.R. Mac
W. Bodemer
F. Schleiflinger
J. Eibl
F. Dorner
Original Assignee
Immuno Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag. filed Critical Immuno Ag.
Priority to YU11991A priority Critical patent/YU11991A/en
Publication of YU11991A publication Critical patent/YU11991A/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

REKOMBINANTNO PROIZVEDENI KRVNI FAKTOR IN POSTOPEK ZA EKSPRESIJO TEH KRVNIH FAKTORJEV KOT TUDI REKOMBINANTI VIRUSA VAKCINIJE, KI JIH UPORABLJAMO V TEM POSTOPKU, opisani so rekombinantno proizvedeni krvni faktorji kot tudi postopek za njihovo pripravo, pri čemer imajo ti krvni faktorji razmerje med biološko aktivno obliko in antigensko obliko najmanj 50%, prednostno v območju 60 do 90%. Opisani so tudi rekombinantni virusi vakcinije, ki jih uporabljamo v gornjem postopku. Postopek v skladu z izumom zagotavlja izboljšan sistem ekspresije z visoko postranslacijsko sposobnostjo pod pogoji stabilne ekspresije.RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINATION VIRUS VIRCOMINANTS USED IN THIS PROCEDURE form at least 50%, preferably in the range of 60 to 90%. The recombinant vaccine viruses used in the above procedure are also described. The process according to the invention provides an improved expression system with high post-translational capacity under stable expression conditions.

YU11991A 1991-01-24 1991-01-24 RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE YU11991A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU11991A YU11991A (en) 1991-01-24 1991-01-24 RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU11991A YU11991A (en) 1991-01-24 1991-01-24 RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE

Publications (1)

Publication Number Publication Date
YU11991A true YU11991A (en) 1994-05-10

Family

ID=47326578

Family Applications (1)

Application Number Title Priority Date Filing Date
YU11991A YU11991A (en) 1991-01-24 1991-01-24 RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE

Country Status (1)

Country Link
YU (1) YU11991A (en)

Similar Documents

Publication Publication Date Title
EA199901031A1 (en) Derivatives of benzimidazole
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DE3750422T2 (en) TRANSLATION OF MRNA.
NO922953D0 (en) RECOMBINANT MANUFACTURED BLOOD FACTORS AND PROCEDURE FOR EXPRESSION OF BLOOD FACTORS, AND VACCINIA VIRUS RECOMBINANTS
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
ATE232109T1 (en) SYNTHETIC MULTIPLE TANDEM REPEATS OF MUCIN PEPTIDE AND ITS DERIVATIVES AND THEIR USE
ATE73348T1 (en) THYMIDINE KINASE DELETION MUTANTS OF BOVINE HERPESVIRUS-1, VACCINES AGAINST BOVINE RHINOTRACHEITIS CONTAINING THEM, AND METHODS FOR THEIR MANUFACTURE AND USE.
NO175406C (en) Process of preparing piroxam in aqueous solution
DK1149910T3 (en) Pharmaceutical preparation for treating papillomavirus tumors and infection
EP0541692A4 (en) Herpes simplex virus vp16 vaccines
ATE101200T1 (en) VACCINES AGAINST HUMAN RESPIRATORY VIRUSES.
GR3003355T3 (en) Nicorandil-containing preparation for injection
EA199800526A1 (en) DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS
DK87190A (en) PROCEDURE FOR REGULATING PLANT GROWTH USING SULFUL ORGANIC ACIDS
YU11991A (en) RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE
DE3068880D1 (en) Carbamates, their preparation and pharmaceutical compositions containing them
DK76688A (en) VACCINE CONTAINING F-PROTEIN FROM AIDS VIRUS
ES2002662A6 (en) Oligomeric diazaoxaspirodecanes, their preparation and their use as light protectors for polymers.
NO301805B1 (en) Process for the preparation of a stable galenic aqueous preparation of erythropoietin
ATE100318T1 (en) USE OF QUINOLYL AND ISOQUINOLYLOXAZOLE-2-ONES IN THE MANUFACTURE OF A MEDICATION FOR PREVENTING THE TRANSPORTABILITY OF GLYCOPROTEIN ENVELOPED VIRUSES.
IT8423675A0 (en) BENZIMIDAZOLE DERIVATIVES, ANTI-ULCERA ADAPTIVENESS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
NO901231D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION